As of 2026-08-19, the Relative Valuation of Medifast Inc (MED) is (38.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.29 USD, the upside of Medifast Inc based on Relative Valuation is -442.6%.
The range of the Relative Valuation is (39.32) - (33.61) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 23.1x | 21.7x |
| Forward P/E multiples | 11.8x - 14.6x | 11.9x |
| Fair Price | (39.32) - (33.61) | (38.68) |
| Upside | -448.3% - -397.7% | -442.6% |
| Date | P/E |
| 2026-08-14 | -4.97 |
| 2026-08-13 | -4.99 |
| 2026-08-12 | -5.03 |
| 2026-08-11 | -5.06 |
| 2026-08-10 | -5.25 |
| 2026-08-07 | -5.48 |
| 2026-08-06 | -5.26 |
| 2026-08-05 | -5.33 |
| 2026-08-04 | -5.68 |
| 2026-08-03 | -4.23 |
| 2026-07-31 | -4.27 |
| 2026-07-30 | -4.30 |
| 2026-07-29 | -4.19 |
| 2026-07-28 | -4.23 |
| 2026-07-27 | -4.30 |
| 2026-07-24 | -4.20 |
| 2026-07-23 | -4.10 |
| 2026-07-22 | -4.24 |
| 2026-07-21 | -4.57 |
| 2026-07-20 | -4.51 |
| 2026-07-17 | -4.46 |
| 2026-07-16 | -4.56 |
| 2026-07-15 | -4.62 |
| 2026-07-14 | -4.61 |
| 2026-07-13 | -4.79 |
| 2026-07-10 | -4.66 |
| 2026-07-09 | -4.64 |
| 2026-07-08 | -4.63 |
| 2026-07-07 | -4.73 |
| 2026-07-06 | -4.80 |
| 2026-07-02 | -4.76 |
| 2026-07-01 | -4.79 |
| 2026-06-30 | -4.61 |
| 2026-06-29 | -4.65 |
| 2026-06-26 | -4.56 |
| 2026-06-25 | -4.43 |
| 2026-06-24 | -4.50 |
| 2026-06-23 | -4.61 |
| 2026-06-22 | -4.79 |
| 2026-06-18 | -4.80 |
| 2026-06-17 | -4.89 |
| 2026-06-16 | -4.90 |
| 2026-06-15 | -5.19 |
| 2026-06-12 | -5.16 |
| 2026-06-11 | -5.18 |
| 2026-06-10 | -5.27 |
| 2026-06-09 | -5.29 |
| 2026-06-08 | -5.24 |
| 2026-06-05 | -5.26 |
| 2026-06-04 | -5.33 |